Transplantation of human skin microbiota in models of atopic dermatitis

JCI Insight

Volumn 1, Issue 10, 2019, Pages

  Myles, Ian A ^a,b   Williams, Kelli W ^a   Reckhow, Jensen D ^a   Jammeh, Momodou L ^a   Pincus, Nathan B ^a   Sastalla, Inka ^a   Saleem, Danial ^a   Stone, Kelly D ^a   Datta, Sandip K ^a  

^a NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES   (United States)

^b NONE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

GAMMA INTERFERON; INTERLEUKIN 17; INTERLEUKIN 17F; INTERLEUKIN 4; INTERLEUKIN 6;

ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; ATOPIC DERMATITIS; BACTERIAL STRAIN; BACTERIOTHERAPY; BACTERIUM CULTURE; COMMENSALISM; CONTROLLED STUDY; HUMAN; IMMUNOREACTIVITY; INNATE IMMUNITY; LIPID ANALYSIS; MOUSE; NONHUMAN; PATHOGENESIS; SKIN MICROBIOTA TRANSPLANTATION; STAPHYLOCOCCUS AUREUS;

EID: 85048301239     PISSN: None     EISSN: 23793708     Source Type: Journal    
DOI: 10.1172/jci.insight.86955     Document Type: Article

References (53)

1. Lyons JJ, Milner JD, Stone KD. Atopic dermatitis in children: clinical features, pathophysiology, and treatment. Immunol Allergy Clin North Am. 2015;35(1):161–183.
2. Boguniewicz M, Leung DY. The abc’s of managing patients with severe atopic dermatitis. J Allergy Clin Immunol. 2013;132(2):511–2.e5.
3. Kobayashi T, et al. Dysbiosis and staphylococcus aureus colonization drives inflammation in atopic dermatitis. Immunity. 2015;42(4):756–766.
4. Kong HH, et al. Temporal shifts in the skin microbiome associated with disease flares and treatment in children with atopic dermatitis. Genome Res. 2012;22(5):850–859.
5. Myles IA, Reckhow JD, Williams KW, Sastalla I, Frank KM, Datta SK. A method for culturing Gram-negative skin microbiota. BMC Microbiol. 2016;16(1):60.
6. Oh J, et al. Biogeography and individuality shape function in the human skin metagenome. Nature. 2014;514(7520):59–64.
7. Grice EA, Segre JA. The skin microbiome. Nat Rev Microbiol. 2011;9(4):244–253.
8. Schlievert PM, Strandberg KL, Lin YC, Peterson ML, Leung DY. Secreted virulence factor comparison between methicil-lin-resistant and methicillin-sensitive Staphylococcus aureus, and its relevance to atopic dermatitis. J Allergy Clin Immunol. 2010;125(1):39–49.
9. Nakamura Y, et al. Staphylococcus -toxin induces allergic skin disease by activating mast cells. Nature. 2013;503(7476):397–401.
10. Brauweiler AM, Goleva E, Leung DY. Th2 cytokines increase Staphylococcus aureus alpha toxin-induced keratinocyte death through the signal transducer and activator of transcription 6 (STAT6). J Invest Dermatol. 2014;134(8):2114–2121.
11. Follin P, Dahlgren C. A skin chamber technique as a human model for studies of aseptic inflammatory reactions. Methods Mol Biol. 2007;412:333–346.
12. Miller J, Gallo RL. Vitamin D and innate immunity. Dermatol Ther. 2010;23(1):13–22.
13. Schauber J, Gallo RL. The vitamin D pathway: a new target for control of the skin’s immune response? Exp Dermatol. 2008;17(8):633–639.
14. Carneiro AB, et al. Lysophosphatidylcholine triggers TLR2- and TLR4-mediated signaling pathways but counteracts LPS-induced NO synthesis in peritoneal macrophages by inhibiting NF-κB translocation and MAPK/ERK phosphorylation. PLoS One. 2013;8(9):e76233.
15. Kabarowski JH, Xu Y, Witte ON. Lysophosphatidylcholine as a ligand for immunoregulation. Biochem Pharmacol. 2002;64(2):161–167.
16. Ryborg AK, Grøn B, Kragballe K. Increased lysophosphatidylcholine content in lesional psoriatic skin. Br J Dermatol. 1995;133(3):398–402.
17. Iyer SS, et al. Mitochondrial cardiolipin is required for Nlrp3 inflammasome activation. Immunity. 2013;39(2):311–323.
18. Wan M, et al. Oxidized but not native cardiolipin has pro-inflammatory effects, which are inhibited by Annexin A5. Atherosclerosis. 2014;235(2):592–598.
19. Fluhr JW, Feingold KR, Elias PM. Transepidermal water loss reflects permeability barrier status: validation in human and rodent in vivo and ex vivo models. Exp Dermatol. 2006;15(7):483–492.
20. Boguniewicz M, Leung DY. Recent insights into atopic dermatitis and implications for management of infectious complications. J Allergy Clin Immunol. 2010;125(1):4–13.
21. Pyun BY. Natural history and risk factors of atopic dermatitis in children. Allergy Asthma Immunol Res. 2015;7(2):101–105.
22. Kelleher M, et al. Skin barrier dysfunction measured by transepidermal water loss at 2 days and 2 months predates and predicts atopic dermatitis at 1 year. J Allergy Clin Immunol. 2015;135(4):930–5.e1.
23. Bantz SK, Zhu Z, Zheng T. The atopic march: progression from atopic dermatitis to allergic rhinitis and asthma. J Clin Cell Immunol. 2014;5:2.
24. Hon KL, Leung AK, Barankin B. Barrier repair therapy in atopic dermatitis: an overview. Am J Clin Dermatol. 2013;14(5):389–399.
25. Jensen JM, Proksch E. The skin’s barrier. G Ital Dermatol Venereol. 2009;144(6):689–700.
26. Leyva-Castillo JM, Hener P, Jiang H, Li M. TSLP produced by keratinocytes promotes allergen sensitization through skin and thereby triggers atopic march in mice. J Invest Dermatol. 2013;133(1):154–163.
27. Elentner A, et al. Langerhans cells are critical in the development of atopic dermatitis-like inflammation and symptoms in mice. J Cell Mol Med. 2009;13(8B):2658–2672.
28. Wang Q, Du J, Zhu J, Yang X, Zhou B. Thymic stromal lymphopoietin signaling in CD4(+) T cells is required for TH2 memory. J Allergy Clin Immunol. 2015;135(3):781–91.e3.
29. Li M, Hener P, Zhang Z, Ganti KP, Metzger D, Chambon P. Induction of thymic stromal lymphopoietin expression in keratinocytes is necessary for generating an atopic dermatitis upon application of the active vitamin D3 analogue MC903 on mouse skin. J Invest Dermatol. 2009;129(2):498–502.
30. Rebane A, et al. MicroRNA-146a alleviates chronic skin inflammation in atopic dermatitis through suppression of innate immune responses in keratinocytes. J Allergy Clin Immunol. 2014;134(4):836–847.e11.
31. Li M, Hener P, Zhang Z, Kato S, Metzger D, Chambon P. Topical vitamin D3 and low-calcemic analogs induce thymic stromal lymphopoietin in mouse keratinocytes and trigger an atopic dermatitis. Proc Natl Acad Sci U S A. 2006;103(31):11736–11741.
32. Lewis-Jones S. Quality of life and childhood atopic dermatitis: the misery of living with childhood eczema. Int J Clin Pract. 2006;60(8):984–992.
33. Zhao LP, et al. Association of SPINK5 gene polymorphisms with atopic dermatitis in Northeast China. J Eur Acad Dermatol Venereol. 2012;26(5):572–577.
34. Kawashima T, et al. Linkage and association of an interleukin 4 gene polymorphism with atopic dermatitis in Japanese families. J Med Genet. 1998;35(6):502–504.
35. Tsunemi Y, et al. Interleukin-13 gene polymorphism G4257A is associated with atopic dermatitis in Japanese patients. J Dermatol Sci. 2002;30(2):100–107.
36. Bieber T. Atopic dermatitis. N Engl J Med. 2008;358(14):1483–1494.
37. Gong JQ, et al. Skin colonization by Staphylococcus aureus in patients with eczema and atopic dermatitis and relevant combined topical therapy: a double-blind multicentre randomized controlled trial. Br J Dermatol. 2006;155(4):680–687.
38. Williams MR, Gallo RL. The role of the skin microbiome in atopic dermatitis. Curr Allergy Asthma Rep. 2015;15(11):65.
39. Gilani SJ, Gonzalez M, Hussain I, Finlay AY, Patel GK. Staphylococcus aureus re-colonization in atopic dermatitis: beyond the skin. Clin Exp Dermatol. 2005;30(1):10–13.
40. Tsai YC, et al. Resolving the complexity of human skin metagenomes using single-molecule sequencing. MBio. 2016;7(1):e01948–e01915.
41. Otto M. Staphylococcus colonization of the skin and antimicrobial peptides. Expert Rev Dermatol. 2010;5(2):183–195.
42. Sugimoto S, et al. Staphylococcus epidermidis Esp degrades specific proteins associated with Staphylococcus aureus biofilm formation and host-pathogen interaction. J Bacteriol. 2013;195(8):1645–1655.
43. Cogen AL, et al. Selective antimicrobial action is provided by phenol-soluble modulins derived from Staphylococcus epidermidis, a normal resident of the skin. J Invest Dermatol. 2010;130(1):192–200.
44. Jin H, He R, Oyoshi M, Geha RS. Animal models of atopic dermatitis. J Invest Dermatol. 2009;129(1):31–40.
45. Gueniche A, et al. Effects of nonpathogenic gram-negative bacterium Vitreoscilla filiformis lysate on atopic dermatitis: a prospective, randomized, double-blind, placebo-controlled clinical study. Br J Dermatol. 2008;159(6):1357–1363.
46. Lau AF, et al. A rapid matrix-assisted laser desorption ionization-time of flight mass spectrometry-based method for single-plasmid tracking in an outbreak of carbapenem-resistant Enterobacteriaceae. J Clin Microbiol. 2014;52(8):2804–2812.
47. Lau AF, Drake SK, Calhoun LB, Henderson CM, Zelazny AM. Development of a clinically comprehensive database and a simple procedure for identification of molds from solid media by matrix-assisted laser desorption ionization-time of flight mass spectrometry. J Clin Microbiol. 2013;51(3):828–834.
48. Youn JH, Drake SK, Weingarten RA, Frank KM, Dekker JP, Lau AF. Clinical performance of a matrix-assisted laser desorption ionization-time of flight mass spectrometry method for detection of certain blakpc-containing plasmids. J Clin Microbiol. 2016;54(1):35–42.
49. Stevenson LG, Drake SK, Shea YR, Zelazny AM, Murray PR. Evaluation of matrix-assisted laser desorption ionization-time of flight mass spectrometry for identification of clinically important yeast species. J Clin Microbiol. 2010;48(10):3482–3486.
50. Saleeb PG, Drake SK, Murray PR, Zelazny AM. Identification of mycobacteria in solid-culture media by matrix-assisted laser desorption ionization-time of flight mass spectrometry. J Clin Microbiol. 2011;49(5):1790–1794.
51. [No authors listed]. Protein precipitation using ammonium sulfate. Curr Protoc Protein Sci. 2016;84(A 3F 1-9).
52. Wijesinghe DS, Chalfant CE. Systems-level lipid analysis methodologies for qualitative and quantitative investigation of lipid signaling events during wound healing. Adv Wound Care (New Rochelle). 2013;2(9):538–548.
53. Myles IA, et al. Signaling via the IL-20 receptor inhibits cutaneous production of IL-1 and IL-17A to promote infection with methicillin-resistant Staphylococcus aureus. Nat Immunol. 2013;14(8):804–811.